This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Michael John Dipierro: Innovator in Pharmaceutical Chemistry
Introduction
Michael John Dipierro is a notable inventor based in Gurnee, Illinois. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of erythromycins. His work has implications for antibiotic development and therapeutic applications.
Latest Patents
Michael John Dipierro holds a patent for a process titled "Process for preparation of 4'-deoxyerythromycins A and B." This innovative process involves the preparation of 4'-deoxyerythromycins, characterized by the formula wherein R is H or OH, and R¹ is H or loweralkyl. The method utilizes the starting material 2'-O-acetyl-4'-imidazolylthionocarbonyl-erythromycin, treated with the radical initiator 4,4'-azobis-(4-cyanovaleric acid), H₃PO₂, and an organic base in a water-miscible solvent. In a preferred embodiment, the solvent is an alcohol, and the deoxygenation and deacetylation occur in a single step. This patent highlights his expertise in chemical processes that enhance the efficacy of antibiotic compounds.
Career Highlights
Michael John Dipierro is associated with Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott has allowed him to engage in cutting-edge research and development in pharmaceuticals. His contributions have been instrumental in advancing the company's mission to improve health outcomes through innovative solutions.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Shyamal I Parekh and Alexandra E Graham. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael John Dipierro's work exemplifies the spirit of innovation in pharmaceutical chemistry. His patent for the preparation of 4'-deoxyerythromycins showcases his commitment to advancing medical science. His contributions continue to impact the field positively, paving the way for future developments in antibiotic therapies.